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ABSTRACT 
Introduction 
We investigated the influence of COVID-19 on smoking patterns in Pakistan.  
Methods 
In a longitudinal survey, we asked cigarette smokers in Pakistan about their smoking behaviours 
before and since COVID-19. Smokers were recruited before COVID-19 using two-stage random 
probability sampling. Since COVID-19, three subsequent waves were conducted over the telephone, 
asking additional questions on social determinants, mental health and wellbeing. Based on the first 
two waves, we estimated the proportion of smokers who stopped, decreased, maintained, or 
increased smoking. We also explored any factors associated with the change in smoking patterns. In 
those who stopped smoking soon after COVID-19, we estimated the proportion relapsed in 
subsequent waves. We estimated all proportions based on complete-case analysis. 
Results 
We recruited 6,014 smokers between September 2019 and February 2020; of these, 2,087 (2,062 
reported smoking outcomes) were followed up in May 2020 after COVID-19. Since COVID-19, 14% 
(290/2,062) smokers reported quitting. Among those who continued smoking: 68% (1210/1772) 
reduced, 14% (239/1772) maintained, and 18% (323/1772) increased cigarette consumption; 37% 
(351/938) reported at least one quit attempt; 41% (669/1619) were more motivated while 21% 
(333/1619) were less motivated to quit. Changes in smoking patterns varied with nicotine 
dependence, motivation to quit, and financial stability since COVID-19. Among those reporting 
quitting soon after COVID-19, 39% (81/206) relapsed in the subsequent months (June-July 2020). 
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Conclusions 
There have been significant bidirectional changes in smoking patterns since COVID-19 in Pakistan. 
While many people stopped, reduced, or tried quitting smoking, some increased smoking, and some 
relapsed after quitting.  
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Implications  
We observed significant and complex changes in people’s smoking patterns, which are likely to be 
attributable to the COVID-19 pandemic and replicated in similar events in the future. Assessing these 
changes are essential for most low- and middle-income countries like Pakistan, where the vast 
majority of tobacco users live, but cessation support is still rudimentary. If provided routinely, 
smoking cessation interventions can potentially support millions of highly motivated individuals in 
quitting successfully both in general as well as in global events like COVID-19, in particular. 
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INTRODUCTION 
Considered as the most significant challenge since World War II,1 COVID-19 has infected over 24 
million individuals worldwide so far. The pandemic and the subsequent measures e.g. social 
distancing, self-isolation, and lockdowns have led to business closures, loss of income,2 and 
livelihoods, and a rise in mental distress.3 With vast swathes of the global population worried about 
the virus, suffering from economic distress and living in social isolation, an impact on health 
behaviours is inevitable.4 The trajectory of health risk behaviours such as alcohol consumption, 
smoking, physical activity, and dietary habits is important to document due to their long-term 
consequences. For example, even small scale changes in tobacco use consumed by over a billion 
people worldwide,5 could lead to major shifts in future disease burden. More importantly, a better 
understanding of the magnitude and nature of such behaviour change can help services and 
policymakers to respond in an agile and effective manner.     
The interaction between COVID-19 and smoking behaviour is likely to be complex and bidirectional. 
It is suggested that COVID-19 might have led to a reduction or stopping smoking in some but an 
increase in others.6 The evidence on the effect of smoking on COVID-19 is still emerging;7 with much 
uncertainty on whether smoking is linked with COVID-19 infection, hospitalisation or mortality.8 In 
addition to such potential risks, access (business closures), affordability (loss of income) and 
opportunity (lockdowns) to smoke might have driven down its use.9 Similarly, for some tobacco 
users, mental stress, anxiety, social isolation, and lack of access to cessation support might have 
resulted in increased consumption.10 The evidence, mostly from high-income countries, suggests 
that while an unusual number of smokers have been motivated to quit during the pandemic11 and 
have either cut down smoking or made quit attempts,9 there are some who increased smoking.12 
There is little information so far on those quitting after the outbreak and maintaining abstinence. 
There is also little evidence on the impact of COVID-19 on smoking patterns in low- and middle-
income countries (LMICs), where most of the world tobacco users now reside.5 LMICs are at 
different stages of the tobacco epidemic, and some of the factors mediating between COVID-19 and 
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smoking may act out differently in LMICs due to contextual differences.13 In this study, we aimed to 
assess the impact of COVID-19 on smoking patterns in Pakistan; we also explored which factors 
might have influenced any change in smoking behaviour.  
METHODS 
Design 
We conducted a longitudinal survey among regular cigarette smokers in the ten most populous cities 
of Pakistan. The first survey wave was conducted face-to-face, prior to the COVID-19 (Sept 2019-Feb 
2020) outbreak in Pakistan (where the first case was recorded on March 12th) and the subsequent 
three waves soon after (May-July 2020). As lockdowns were imposed from 24th March 2020, 
ordering all public transport, markets, offices, shopping malls, restaurants, and public areas to be 
shut down, data for these subsequent waves were collected over the telephone. 
Participants and sampling methods 
Before COVID-19 (wave 1), we recruited people aged 15+ who smoke at least 25 out of the last 30 
days for at least six months. Househol s were identified using a two-stage random probability 
sampling. At the first stage, we used stratified random sampling to select 346 Union Councils (UCs) 
from the ten most populous cities. We assessed which households were eligible (at least one smoker 
aged 15+) in these UCs and then randomly selected 20 households at the second stage. One 
participant per household was identified using Kish Grid method14 and recruited after informed 
consent.  
Data collection 
Data were collected in password-protected digital tablets by field investigators in real-time. At wave 
1, participants were asked about socio-demographic characteristics including age, education (no 
formal education, education till primary, secondary or high school, and graduation or above) and 
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smoking behaviours including using Motivation To Stop Smoking (MTSS),15 Strength of Urges to 
Smoke (SUTS)16 and Heaviness of Smoking Index (HSI)16 scales. 
Since the COVID-19 outbreak in Pakistan, those who consented for follow-up over the phone were 
surveyed in three consecutive waves. To explore changes in their smoking behaviour during the 
pandemic, we asked the participants to choose from the following options: (i) I smoke cigarettes 
every day, (ii) I smoke cigarettes, but not every day, (iii) I smoke cigarettes, but I also smoke tobacco 
in other forms, (iv) I smoke tobacco, but I also use smokeless tobacco, (v) I have stopped smoking 
cigarettes, but I smoke other form(s) of tobacco (bidi/water pipe/cigar), (vi) I have stopped smoking 
tobacco, but I continue to use smokeless tobacco, (vii) I have stopped smoking tobacco but now I use 
smokeless tobacco, and (viii) I have stopped using all forms of tobacco. We also repeated MTSS and 
asked about the number of cigarettes/day and quit attempts made in the last six months. We used 
the above to define new variables and estimate proportions stopped, increased, maintained, or 
decreased cigarette smoking. Additional variables were created to identify those that stopped 
smoking cigarettes, this included individuals who continued other forms of tobacco smoking or 
smokeless tobacco. 
We included additional derived variables at wave 2 e.g. housing security (concerned about 
eviction/non-payment of rent [Yes/No]), food security (had less food or went hungry [Yes/No]), 
status of the main earner (unemployed, employed but likely to lose job, employed and not likely to 
lose job), change in financial well-being in the past 3 months (worse off, about the same, better off), 
PHQ-917 for depression (none, mild, moderate, moderately severe, severe), GAD-718 for anxiety 
(none, mild, moderate, severe) and Warwick-Edinburgh Mental and Wellbeing Scale19 for general 
health and well-being.  
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Statistical Analysis 
A descriptive analysis reported changes in smoking behaviours during the pandemic, using data from 
participants who completed both the first and second waves. We estimated the overall proportion 
of smokers who quit smoking and those who decreased, maintained or increased their cigarette 
consumption since wave 1. We also estimated the proportion of quitters at wave 2 relapsing in 
subsequent waves. We estimated all proportions based on complete-case analysis. We explored 
associations between socio-demographic, smoking-related, psychosocial health and well-being 
measures and the change in smoking behaviours; we focussed on two sub-groups, i.e. those who 
reported complete abstinence and those reporting an increase in their cigarette consumption at 
wave 2. We reported bi-variate associations for age using independent student’s t-test, and for 
categorical variables using chi-square test of independence. Alternatively, Fisher's exact test was 
used in comparisons where expected cell counts were <5. Statistical analyses were performed on 
STATA version 16. 
Ethics approval for wave 1 was given on 20th June 2019 and for waves 2, 3 and 4 on 15th April 2020 
by the National Bioethics Committee, Pakistan. 
RESULTS 
We recruited 6,014 adult smokers between September 2019 and February 2020. Of these, contact 
details for a phone-based follow up were provided by 4,132 participants. We contacted 3,342 of 
these participants between 5th May 2020 and 4th June 2020 for wave 2. Data collection was carried 
out on 2,087 (62.5%) smokers - reasons for non-participation were incorrect telephone numbers 
(n=321), non-response (n=875), refusal to participate (n=46) and deaths (n=13). In the two 
subsequent waves, data were collected on 2,327 and 2,219 participants between 5th of June 2020 
and 24th of June 2020 and between 25th of June 2020 and 15th of July 2020, respectively. The key 
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socio-demographic and smoking characteristics of those followed up in comparison to those not 
followed-up are presented as supplementary material.  
Of all participants (2,062 reported smoking outcomes) at wave 2, 14% (290/2062) stopped smoking 
cigarettes completely; 13.5% (279/2062) stopped using all forms of tobacco; 11 stopped smoking 
cigarettes but continued either smoking other forms of tobacco (6) or using smokeless tobacco (5).  
Of those who stopped smoking cigarettes at wave 2 and were followed-up in subsequent waves, 
39.3% (81/206) relapsed either at wave 3 or 4. Among those who were still smoking at wave 2: 68% 
(1210/1772) reduced, 14% (239/1772) maintained, and 18% (323/1772) increased cigarette 
consumption at wave 2. Moreover, the mean number of cigarettes/day dropped from 14 to 9 
cigs/day. Among those smoking at wave 2, 37% (351/938) made at least one quit attempt; 41% 
(669/1619) were more motivated and 21% (333/1619) were less motivated to quit according to 
MTSS. 
Table 1 describes the distribution of socio-demographic and smoking variables (collected at wave 1) 
in those who were followed-up at wave 2; it also examines any statistically significant differences 
between those who stopped smoking vs. those who continued as well as between those who 
increased their smoking vs. the rest. Those who stopped smoking were more motivated to quit and 
were less nicotine dependent as per HSI and SUTS measured at wave 1 than those who continued. 
Those who increased their smoking were more likely to be single and on average younger and less 
dependent on tobacco than the rest of the cohort. These differences were statistically significant. 
Table 2 describes the distribution of social determinants, mental health and well-being variables 
(collected at wave 2) and assesses any statistically significant differences between the two 
categories i.e. those who stopped and those who increased smoking and the rest. More people who 
stopped smoking appear to be financially worse off and likely to lose their jobs as compared to those 
who continued smoking. These differences were statistically significant. On the contrary, those who 
increased smoking were a little more financially stable than those who didn’t. On mental health 
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(GAD-7 and PHQ-9) and wellbeing (WEMWBS), we did not find any evidence of statistically 
significant differences between the groups.  
 
 
 
DISCUSSION 
We report findings mainly from wave 2 of a longitudinal study in which smokers, recruited just 
before COVID-19, were followed up in successive waves to study changes in their smoking 
behaviour. We observed significant bidirectional changes. An estimated one in seven participants 
reported quitting after COVID-19 restrictions and among those who continued, more than two-thirds 
reduced their cigarette consumption. One-third made at least one quit attempt and 41% were more 
motivated to quit. Participants with lower nicotine dependency and greater financial concerns were 
more likely to quit than those who continued. On the other hand, 18% increased their smoking 
frequency, one in five smokers were less motivated to quit than before and 39% relapsed after 
quitting. Those who increased their smoking were less nicotine dependent and a little more 
financially stable than those who did not. No significant associations were found between changes in 
smoking behaviour and mental health and well-being.  
Our findings are consistent with previous studies reporting a bidirectional effect of COVID-19 
observed in smokers.6,10,11 In one of these, Klemperer et al found that in response to COVID-19, the 
motivation to quit increased in 35.6% but reduced in 16.2% of smokers;11 fear of COVID-19 was 
associated with a change in motivation. Likewise, 22.9% smokers made at least one quit attempt, 
28.3% decreased their cigarette use, but another 30.3% increased its use since COVID-19.11 In 
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another group of cigar users, while two-third participants intended to quit and nearly half made a 
quit attempt, far more smokers reported increasing their smoking than those reporting a decline.10 
Our paper describes self-reported changes in smoking behaviour in a large sample of a nationally 
representative cohort of smokers. To our knowledge, this is the only study that reports relapse rates 
among those who stopped soon after COVID-19 outbreak. However, there are several weaknesses 
that may limit its external validity. While the first wave of data collection finished just before COVID-
19, it started a few months before the pandemic. It is possible that some of the reported changes 
might have happened before COVID-19.  However, the scale of change is significant indicating an 
attribution to the outbreak. For example, the number of smokers making at least one quit attempt in 
the last six months reported at wave 2 (37%) was significantly higher than that reported for the last 
12 months at wave 1 (28%) and Pakistan’s Global Adult Tobacco Survey (25%). We didn’t observe 
any structural changes that might have led to a disproportionate change in smoking patterns (e.g. 
tobacco taxes remained unchanged during this period). Seasonal variations can influence smoking 
behaviours but we were not able to confirm or adjust our estimates due to lack of local data.  We 
were only able to reach a third of our cohort in the second wave. While this limits the external 
validity of our findings, the reasons for this non-response is unlikely to be linked to their smoking 
status except in those who refused (only 1.3% of everyone contacted). A comparison between those 
followed up in any of the three waves (2-4) and those not followed up revealed small but statistically 
significant differences in relation to sex, education status and addiction levels (see supplementary 
materials). Reasons for the changes in smoking behaviours were not recorded in this study; but 
relevant questions will be included in the future waves. We were only able to report short-term 
abstinence and the future waves can also assess long-term abstinence. Finally, self-reported smoking 
status is always less accurate than that validated biochemically, a limitation that we could not 
overcome in a telephone-based survey. 
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Smoking cessation treatment could have converted an unusually high number of quit attempts 
observed among smokers during COVID-19 into permanent abstinence. In a study in Wuhan, more 
people were successful in quitting (31.1%) following treatment than the success rates observed 
before COVID-19 (23.7%).20 Most LMICs have very limited access to smoking cessation treatments. 
An increased interest in quitting in global events like COVID-19 further underlines the need to 
support those who are likely to quit. Healthcare professionals could use their patients’ concern 
about COVID-19 as a ‘teachable moment’ to help them quit. Offering smoking cessation treatment 
by implementing Article 14 of the WHO Framework Convention for Tobacco Control should become 
an even greater priority for countries like Pakistan where millions of smokers are willing to quit but 
have little access to cessation interventions. 
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Table 1:  Socio-demographic and smoking characteristics of participants and their smoking behaviour at wave 2 of the survey (n=2062). Counts and (%) are 
presented unless specified 
 Total sample Quit smoking Continued 
smoking 
P value Increased 
smoking 
Didn’t 
increase 
smoking  
p value 
2062 290 1772  323 1739  
Age (in years)* (mean+SD) 45.0 +14.5 45.7+16.1 44.9.1+14.2 0.39 43.4+15.3 45.3+14.3 0.03 
Education 
No formal education 
Up to primary education  
Up to secondary education 
High school  
Graduation or above 
Missing  
 
567 (27.5) 
485 (23.5) 
588 (28.5) 
177 (8.6) 
148 (7.2) 
97 (4.7) 
 
99 (34.2) 
57 (19.6) 
78 (26.9) 
23 (7.9) 
24 (8.3) 
9 (3.1) 
 
468 (25.6) 
428 (22.3) 
510 (28.0) 
154 (9.6) 
124 (7.4) 
88 (7.1) 
 
0.06** 
 
88 (27.2) 
93 (28.8) 
99 (30.6) 
24 (7.4) 
18 (5.6) 
1 (0.4) 
 
479 (27.5) 
392 (22.5) 
489 (28.1) 
153 (8.9) 
130 (7.5) 
96 (5.5) 
 
0.19 ** 
Marital status 
Single 
 
267 (12.9) 
 
41 (14.1) 
 
226 (12.75) 
 
0.34** 
 
62 (19.2) 
 
205 (11.8) 
 
0.003** 
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Married 
Separated/divorced/widowed 
missing 
1644 (79.7) 
57 (2.7) 
94 (4.5) 
231 (79.7) 
10 (3.4) 
8 (2.8) 
1413 (79.7) 
47 (2.6) 
86 (4.85) 
249 (77.1) 
12 (3.7) 
0 (0) 
1395 (80.2) 
45 (2.6) 
94 (5.4) 
 
Heaviness of Smoking Index 
Low  
Medium  
High 
Missing 
(mean+SD) 
 
337 (16.3) 
1291 (62.6) 
203 (9.8) 
231 (11.2) 
2.5+1.0 
 
43 (14.8) 
190 (65.5) 
14 (4.8) 
43 (14.8) 
2.4+0.8 
 
294 (16.6) 
1101 (62.1) 
189 (10.7) 
188 (10.6) 
2.5+1.0 
 
0.009** 
 
44 (13.6) 
227 (70.3) 
7 (2.2) 
45 (13.9) 
2.4+0.9 
 
293 (16.8) 
1064 (61.2) 
196 (11.3) 
186 (10.7) 
2.4+1.0 
 
<0.001** 
 
Strength of Urge To Smoke  
None 
Slight  
Moderate 
Strong 
Very strong 
Extremely strong 
missing 
(mean+SD) 
 
140 (6.8) 
339 (16.4) 
797(38.6) 
479 (23.2) 
133 (6.4) 
80 (3.8) 
94(4.5) 
2.2 +1.1 
 
37 (12.7) 
78 (26.9) 
94 (32.4) 
53 (18.3) 
15 (5.2) 
5 (1.7) 
8 (2.7) 
1.8+1.1 
 
103 (5.8) 
261 (14.7) 
703 (39.6) 
426 (24.0) 
118 (6.6) 
75 (4.2) 
86 (4.8) 
2.2+1.1 
 
<0.001** 
 
 
44 (13.6) 
100 (30.9) 
121 (37.5) 
41 (12.7) 
13 (4.0) 
4 (1.2) 
0 (0) 
1.66+1.0 
 
96 (5.5) 
239 (13.7) 
676 (38.9) 
438 (25.2) 
120 (6.9) 
76 (4.4) 
94 (5.4) 
2.3+1.1 
 
<0.001** 
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Motivation to stop smoking  
No desire or intention to quit 
Desire to quit  
Desire and intention to quit 
missing 
 
904 (43.8) 
764 (37.0) 
279 (13.5) 
115 (5.6) 
 
119 (41.0) 
100 (34.5) 
56 (19.3) 
15 (5.2) 
 
785 (44.3) 
664 (37.4) 
223 (12.5) 
100 (5.6) 
 
0.009** 
 
141 (43.7) 
132 (40.9) 
46 (14.2) 
4 (1.2) 
 
763 (43.9) 
632 (36.3) 
233 (13.4) 
111 (6.4) 
 
0.65** 
 
* Student’s t-test  
** test statistics represent only non-missing values 
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Table 2.  Social determinants, mental health and well-being of participants and their smoking behaviour at wave 2 of the survey (n=2062). Counts and (%) are 
presented unless specified.  
 Overall Quit 
smoking  
Continued 
smoking  
p value Increased 
smoking  
Didn’t increase 
smoking 
p value 
Food security 
No 
Yes 
 
661 (32.1) 
1401 (67.9) 
 
92 (31.7) 
198 (68.3) 
 
1203 (67.9) 
569 (32.1) 
 
0.89 
 
84 (26.0) 
239 (74.0) 
 
577 (33.1) 
1162(66.9) 
 
0.01 
Housing security 
No  
Yes 
 
681 (33.1) 
1381 (66.9) 
 
73 (25.2) 
217 (74.8) 
 
1164 (65.7) 
608 (34.3) 
 
0.002 
 
112 (34.7) 
211 (65.3) 
 
569 (32.7) 
1170 (67.3) 
 
0.49 
Financial situation since 3 months ago 
Worse  
Better/same as before 
Don’t know/don’t wish to answer 
 
1454 (70.5) 
484 (23.5) 
124 (6.0) 
 
221 (76.2) 
67 (23.1) 
2 (0.7) 
 
1233 (69.6) 
417 (23.5) 
122 (6.9) 
 
<0.001 
 
205 (63.5) 
94 (29.1) 
24 (7.4) 
 
1249 (71.8) 
390 (22.4) 
100 (5.8) 
 
0.01 
 
The main earner 
Unemployed 
Employed, likely to lose job 
Employed, unlikely to lose job 
 
703 (34.1) 
352 (17.0) 
956 (46.4) 
 
100 (34.5) 
65 (22.4) 
114 (39.3) 
 
603 (34.0) 
287 (16.2) 
842 (47.5) 
 
0.009** 
 
104 (32.2) 
39 (12.1) 
172 (53.2) 
 
599 (34.4) 
313 (18.0) 
784 (45.1) 
 
0.01** 
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Missing 51 (2.5) 11 (3.8) 40 (2.2) 8 (2.5) 43 (2.5) 
Health status  
Good 
Fair 
Poor 
Don’t know/Don't wish to answer 
 
1798 (87.2) 
220 (10.7) 
38 (1.8) 
6 (0.3) 
 
254 (87.6) 
31 (10.7) 
5 (1.7) 
0 (0) 
 
1544 (87.1) 
189 (10.7) 
33 (1.8) 
6 (0.3) 
 
0.98 
 
277 (85.8) 
40 (12.4) 
3 (0.9) 
3 (0.9) 
 
 1521(87.5) 
180 (10.4) 
35 (2.0) 
3 (0.1) 
 
0.04 
Anxiety (GAD 7) 
None  
Mild  
Moderate 
Severe 
Mean +SD 
 
1001 (48.6) 
763 (37.0) 
200 (9.7) 
97 (4.7) 
5.0+4.3 
 
149 (51.6) 
94 (32.5) 
31 (10.7) 
15 (5.2) 
4.8+4.5 
 
846 (47.9) 
669 (37.9) 
169 (9.6) 
82 (4.6) 
5.0+4.3 
 
0.39 
 
150 (46.4) 
128 (39.6) 
29 (8.9) 
16 (4.9) 
5.0+4.4 
 
851 (48.9) 
635 (36.5) 
171 (9.8) 
81 (4.6) 
4.9+4.3 
 
0.72 
Depression (PHQ-9) 
Minimal/non depressed 
Mild 
Moderate 
Moderately severe 
 
1238 (60.1) 
518 (25.2) 
213 (10.3) 
71 (3.5) 
 
178 (62.0) 
72 (25.1) 
20 (6.9) 
12 (4.2) 
 
1054 (59.7) 
446 (25.2) 
193 (10.9) 
59 (3.3) 
 
0.14 
 
202 (62.5) 
69 (21.4) 
42 (13.0) 
8 (2.5) 
 
1036 (59.7) 
449 (25.9) 
171 (9.8) 
63 (3.6) 
 
0.15 
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Severe 
Mean +SD 
19 (0.9) 
4.4+4.8 
5 (1.7) 
4.5+5.34.8 
14 (0.8) 
4.4+4.8 
2 (0.6) 
4.3+4.8 
17 (1.0) 
4.5+4.8 
Warwick-Edinburgh mental and well being 
scores (WEMWBS) Mean +SD 
22.7+4.6 23.2+4.7  22.5+4.6 0.05* 22.7+4.5 22.7+4.6 0.94* 
* Student’s t-test   
** test statistics represent only non-missing values
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